Ku E - Search Results

1

Acute Declines in Renal Function during Intensive BP Lowering: Implications for Future ESRD Risk.

Ku E, Bakris G, Johansen KL, Lin F, Sarnak MJ, Campese VM, Jamerson K, Gassman JJ, Smogorzewski M, Hsu CY. Ku E, et al. J Am Soc Nephrol. 2017 Sep;28(9):2794-2801. doi: 10.1681/ASN.2017010040. Epub 2017 May 4. J Am Soc Nephrol. 2017. PMID: 28473636 Free PMC article.

2

Role of aldosterone in the progression of chronic kidney disease and potential use of aldosterone blockade in children.

Ku E, Campese VM. Ku E, et al. Pediatr Nephrol. 2009 Dec;24(12):2301-7. doi: 10.1007/s00467-009-1176-z. Epub 2009 Apr 4. Pediatr Nephrol. 2009. PMID: 19347366 Review.

3

Lixivaptan: a novel vasopressin receptor antagonist.

Ku E, Nobakht N, Campese VM. Ku E, et al. Expert Opin Investig Drugs. 2009 May;18(5):657-62. doi: 10.1517/13543780902889760. Expert Opin Investig Drugs. 2009. PMID: 19379124 Review.

4

The hazards of dual renin-angiotensin blockade in chronic kidney disease.

Ku E, Park J, Vidhun J, Campese V. Ku E, et al. Arch Intern Med. 2009 Jun 8;169(11):1015-8. doi: 10.1001/archinternmed.2009.128. Arch Intern Med. 2009. PMID: 19506167 No abstract available.

5

Aldosterone and hypertension in African Americans.

Ku E, Campese VM. Ku E, et al. Am J Hypertens. 2009 Dec;22(12):1234. doi: 10.1038/ajh.2009.174. Am J Hypertens. 2009. PMID: 19924116 No abstract available.

6

Aldosterone in the pathogenesis of chronic kidney disease and proteinuria.

Lu Y, Ku E, Campese VM. Lu Y, et al. Among authors: ku e. Curr Hypertens Rep. 2010 Aug;12(4):303-6. doi: 10.1007/s11906-010-0116-4. Curr Hypertens Rep. 2010. PMID: 20596805 Review.

7

Sympathetic renal innervation and resistant hypertension.

Campese VM, Ku E, Park J. Campese VM, et al. Among authors: ku e. Int J Hypertens. 2011 Jan 20;2011:814354. doi: 10.4061/2011/814354. Int J Hypertens. 2011. PMID: 21331158 Free PMC article.

8

Do HMG-CoA reductase inhibitors improve kidney function? The saga continues.

Campese VM, Ku E, Bigazzi R, Bianchi S. Campese VM, et al. Among authors: ku e. J Nephrol. 2011 Sep-Oct;24(5):550-3. doi: 10.5301/jn.5000024. J Nephrol. 2011. PMID: 21887675 Review.

9

IgA nephropathy in a patient with ulcerative colitis, Graves' disease and positive myeloperoxidase ANCA.

Ku E, Ananthapanyasut W, Campese VM. Ku E, et al. Clin Nephrol. 2012 Feb;77(2):146-50. doi: 10.5414/CN106770. Clin Nephrol. 2012. PMID: 22257545

10

Is lipid management effective for all stages of CKD?

Ku E, Campese V. Ku E, et al. Blood Purif. 2013;35(1-3):26-30. doi: 10.1159/000345932. Epub 2013 Jan 22. Blood Purif. 2013. PMID: 23343543 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters